Catalyst Wire Dossier Catalyst Wire Dossier

Onivyde (liposomal irinotecan)

liposomal irinotecan · Ipsen
Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for Onivyde (liposomal irinotecan), covering 2024-07-12 to 2026-03-03. Get the full timeline:

Most recent: Clinical Trial Update: Liposomal Irinotecan, Vincristine, Temozolomide, and Anlotinib for R/R Pediatric Solid Tumors [Phase 2]

See pricing